Thermo Fisher Scientific has opened its $ 85-million plant for manufacturing niche diagnostics products in Fremont, California. The facility will develop and manufacture innovative technologies for diagnostic testing and quality controls that have applications in healthcare and other markets.
“Our company is at the centre of discovery in many of the most promising areas of science and healthcare today. We are committed to making investments in R&D and manufacturing that strengthen our position as the world leader in serving science so we can continue to grow and support our employees and the local community,” said Marc Casper, President and CEO, Thermo Fisher Scientific.
The facility is now home to more than 500 employees who develop and manufacture next-generation assays for therapeutic drug monitoring, drugs of abuse screening and other ready-to-use tests.
“Our company is at the centre of discovery in many of the most promising areas of science and healthcare today. We are committed to making investments in R&D and manufacturing that strengthen our position as the world leader in serving science so we can continue to grow and support our employees and the local community,” said Marc Casper, President and CEO, Thermo Fisher Scientific.
The facility is now home to more than 500 employees who develop and manufacture next-generation assays for therapeutic drug monitoring, drugs of abuse screening and other ready-to-use tests.